KBL 982
Alternative Names: KBL-982; KBLP-009Latest Information Update: 28 Apr 2023
At a glance
- Originator KoBioLabs
- Class Bacteria; Hepatoprotectants
- Mechanism of Action Bacteria replacements; Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Liver disorders